ES2106888T3 - Sistemas terapeuticos transdermicos con inhibidores de la cristalizacion. - Google Patents

Sistemas terapeuticos transdermicos con inhibidores de la cristalizacion.

Info

Publication number
ES2106888T3
ES2106888T3 ES92922822T ES92922822T ES2106888T3 ES 2106888 T3 ES2106888 T3 ES 2106888T3 ES 92922822 T ES92922822 T ES 92922822T ES 92922822 T ES92922822 T ES 92922822T ES 2106888 T3 ES2106888 T3 ES 2106888T3
Authority
ES
Spain
Prior art keywords
therapeutic systems
crystallization inhibitors
transdermic
transdermic therapeutic
crystallization
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
ES92922822T
Other languages
English (en)
Inventor
Ralph Lipp
Jutta Riedl
Johannes Tack
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Bayer Pharma AG
Original Assignee
Schering AG
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Schering AG filed Critical Schering AG
Application granted granted Critical
Publication of ES2106888T3 publication Critical patent/ES2106888T3/es
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/70—Web, sheet or filament bases ; Films; Fibres of the matrix type containing drug
    • A61K9/7023—Transdermal patches and similar drug-containing composite devices, e.g. cataplasms
    • A61K9/703—Transdermal patches and similar drug-containing composite devices, e.g. cataplasms characterised by shape or structure; Details concerning release liner or backing; Refillable patches; User-activated patches
    • A61K9/7038—Transdermal patches of the drug-in-adhesive type, i.e. comprising drug in the skin-adhesive layer
    • A61K9/7046—Transdermal patches of the drug-in-adhesive type, i.e. comprising drug in the skin-adhesive layer the adhesive comprising macromolecular compounds
    • A61K9/7053—Transdermal patches of the drug-in-adhesive type, i.e. comprising drug in the skin-adhesive layer the adhesive comprising macromolecular compounds obtained by reactions only involving carbon to carbon unsaturated bonds, e.g. polyvinyl, polyisobutylene, polystyrene
    • A61K9/7061—Polyacrylates

Landscapes

  • Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Dermatology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Chemical & Material Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)

Abstract

SE DESCRIBE UN SISTEMA TERAPEUTICO TRANSDERMAL, QUE SE CARACTERIZA PORQUE CONTIENE UN INHIBIDOR DE CRISTALIZACION EN UNA MATRIZ ADHESIVA CONTENIENDO SUSTANCIA ACTIVA Y EN CASO DADO REFORZADOR DE PENETRACION.
ES92922822T 1991-10-31 1992-10-21 Sistemas terapeuticos transdermicos con inhibidores de la cristalizacion. Expired - Lifetime ES2106888T3 (es)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
DE4136057 1991-10-31
DE4210711A DE4210711A1 (de) 1991-10-31 1992-03-27 Transdermale therapeutische systeme mit kristallisationsinhibitoren

Publications (1)

Publication Number Publication Date
ES2106888T3 true ES2106888T3 (es) 1997-11-16

Family

ID=25908725

Family Applications (1)

Application Number Title Priority Date Filing Date
ES92922822T Expired - Lifetime ES2106888T3 (es) 1991-10-31 1992-10-21 Sistemas terapeuticos transdermicos con inhibidores de la cristalizacion.

Country Status (14)

Country Link
EP (1) EP0610357B1 (es)
JP (1) JP3526864B2 (es)
AT (1) ATE158181T1 (es)
AU (2) AU2895392A (es)
CA (1) CA2120599C (es)
DE (2) DE4210711A1 (es)
DK (1) DK0610357T3 (es)
ES (1) ES2106888T3 (es)
FI (1) FI110061B (es)
GR (1) GR3025237T3 (es)
HU (1) HU227531B1 (es)
NO (1) NO307644B1 (es)
PT (1) PT101019B (es)
WO (1) WO1993008795A1 (es)

Families Citing this family (30)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5656286A (en) * 1988-03-04 1997-08-12 Noven Pharmaceuticals, Inc. Solubility parameter based drug delivery system and method for altering drug saturation concentration
DE69401945T3 (de) * 1993-06-25 2004-09-02 Alza Corp., Palo Alto Einarbeitung eines poly-n-vinylamids in ein transdermales system
DE4333595A1 (de) * 1993-10-01 1995-04-06 Labtec Gmbh Transdermales therapeutisches System zur Applikation von Arzneimitteln auf die Haut
DE4405899A1 (de) * 1994-02-18 1995-08-24 Schering Ag Mittel zur transdermalen Applikation enthaltend Desogestrel
DE4429667C2 (de) * 1994-08-20 1996-07-11 Lohmann Therapie Syst Lts Estradiol-TTS mit wasserbindenden Zusätzen und Verfahren zu seiner Herstellung
IL116539A (en) * 1995-01-06 2002-02-10 Noven Pharma Preparations given through the skin of unstable anti-acid drugs
US6024974A (en) * 1995-01-06 2000-02-15 Noven Pharmaceuticals, Inc. Composition and methods for transdermal delivery of acid labile drugs
DE19500662C2 (de) * 1995-01-12 2001-04-26 Lohmann Therapie Syst Lts Estradiolhaltiges Pflaster und seine Verwendung
US5698217A (en) * 1995-05-31 1997-12-16 Minnesota Mining And Manufacturing Company Transdermal drug delivery device containing a desiccant
JP3534775B2 (ja) † 1995-06-07 2004-06-07 オーソ―マクニール ファーマシューティカル，インコーポレイテッド １７−デアセチルノルゲスチマートを単独でまたはエストロゲンと組み合わせて投与するための経皮パッチおよび方法
DE19526864A1 (de) * 1995-07-22 1997-01-23 Labtec Gmbh Hormonpflaster
US5702720A (en) * 1995-12-22 1997-12-30 Minnesota Mining And Manufacturing Company Transdermal device for the delivery of flurbiprofen
DE19629468A1 (de) * 1996-07-11 1998-01-15 Schering Ag Transdermale therapeutische Systeme
DE19649535C2 (de) * 1996-11-29 2000-02-10 Lohmann Therapie Syst Lts Verfahren zur Herstellung eines pflasterförmigen therapeutischen Systems
DE19701949A1 (de) * 1997-01-13 1998-07-16 Jenapharm Gmbh Transdermales therapeutisches System
GB9720470D0 (en) * 1997-09-25 1997-11-26 Ethical Pharmaceuticals South Inhibition of crystallization in transdermal devices
DE19827732A1 (de) * 1998-06-22 1999-12-23 Rottapharm Bv Transdermales System vom Matrix-Typ zur Abgabe von Wirkstoffen mit einer hohen Abgaberate von Steroid-Hormonen und die Verwendung eines derartigen Systems zur Hormonersatztherapie
DE19829713C1 (de) * 1998-07-03 2000-01-05 Lohmann Therapie Syst Lts Therapeutisches System mit Zusatz von Perglanzpigmenten
DE19834006A1 (de) * 1998-07-29 2000-02-24 Lohmann Therapie Syst Lts Estradiolhaltiges Pflaster zur transdermalen Applikation von Hormonen
DE19843027A1 (de) * 1998-09-19 2000-03-23 Labtec Gmbh Neohesperidin DC als Kristallisationsinhibitor
DE10012908B4 (de) * 2000-03-16 2005-03-17 Lts Lohmann Therapie-Systeme Ag Stabilisierte übersättigte transdermale therapeutische Matrixsysteme und Verfahren zu ihrer Herstellung
DE10033853A1 (de) * 2000-07-12 2002-01-31 Hexal Ag Transdermales therapeutisches System mit hochdispersem Siliziumdioxid
IL159415A0 (en) * 2001-06-18 2004-06-01 Noven Pharma Enhanced drug delivery in transdermal systems
AU2004283431B2 (en) 2003-10-10 2009-09-10 Antares Pharma Ipl Ag Transdermal pharmaceutical formulation for minimizing skin residues
WO2006093139A1 (ja) 2005-02-28 2006-09-08 Hisamitsu Pharmaceutical Co., Inc. 経皮吸収製剤
WO2009107478A1 (ja) 2008-02-27 2009-09-03 久光製薬株式会社 貼付剤及び包装体
EP2255809B1 (en) 2008-02-27 2017-08-23 Hisamitsu Pharmaceutical Co., Inc. Medicated patch
WO2009110351A1 (ja) 2008-03-03 2009-09-11 久光製薬株式会社 経皮吸収製剤
DE102010040299A1 (de) 2010-09-06 2012-03-08 Bayer Schering Pharma Aktiengesellschaft Transdermale therapeutische Systeme mit kristallisationsinhibierender Schutzfolie (Release Liner)
ES2841138T3 (es) * 2013-09-11 2021-07-07 Medrx Co Ltd Composición de base novedosa para agente de cinta adhesiva

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB8512358D0 (en) * 1985-05-16 1985-06-19 Euro Celtique Sa Transdermal delivery system
IL86211A (en) * 1987-05-04 1992-03-29 Ciba Geigy Ag Oral forms of administration for carbamazepine in the forms of stable aqueous suspension with delayed release and their preparation
DE3933460A1 (de) * 1989-10-06 1991-04-18 Lohmann Therapie Syst Lts Oestrogenhaltiges wirkstoffpflaster
WO1991005529A1 (en) * 1989-10-13 1991-05-02 Watson Laboratories, Inc. Drug delivery systems and matrix therefor
JPH07116032B2 (ja) * 1990-04-06 1995-12-13 積水化学工業株式会社 ニトログリセリン貼付剤

Also Published As

Publication number Publication date
GR3025237T3 (en) 1998-02-27
CA2120599A1 (en) 1993-05-13
EP0610357A1 (de) 1994-08-17
PT101019A (pt) 1994-02-28
HU9401257D0 (en) 1994-08-29
AU712692B2 (en) 1999-11-11
HU227531B1 (en) 2011-07-28
FI942011A (fi) 1994-04-29
PT101019B (pt) 1999-10-29
ATE158181T1 (de) 1997-10-15
HUT72964A (en) 1996-06-28
NO941593L (no) 1994-04-29
JP3526864B2 (ja) 2004-05-17
WO1993008795A1 (de) 1993-05-13
FI942011A0 (fi) 1994-04-29
DE59208918D1 (de) 1997-10-23
DK0610357T3 (da) 1998-05-11
EP0610357B1 (de) 1997-09-17
AU1652997A (en) 1997-05-29
CA2120599C (en) 2003-04-15
JPH07506083A (ja) 1995-07-06
AU2895392A (en) 1993-06-07
DE4210711A1 (de) 1993-05-06
NO941593D0 (es) 1994-04-29
NO307644B1 (no) 2000-05-08
FI110061B (fi) 2002-11-29

Similar Documents

Publication Publication Date Title
ES2106888T3 (es) Sistemas terapeuticos transdermicos con inhibidores de la cristalizacion.
ES2103952T3 (es) Sistemas terapeuticos transdermicos.
BR9609794A (pt) Sistema terapêutico transdermal (stt)
DE69426988T2 (de) Transdermale abgabe vorrichtung
AR009516A1 (es) Un dispositivo de parche de matriz adhesiva sensible a la presion, un metodo para preparar dicho dispositivo y un metodo para emplear dichodispositivo en el suministro transdermico de una droga.
DE68915413T2 (de) Anzeigevorrichtung mit aktiver Matrix.
ATE162945T1 (de) Mittel zur transdermalen applikation enthaltend 3-keto-desogestrel
DE68924247D1 (de) Anzeigevorrichtung mit aktiver Matrix.
DE69829961D1 (de) Transdermale vorrichtung zur verabreichungvon von testosteron
NO974508D0 (no) Transdermalt administrerbart medikament med ACE-inhibitorer
ES2156220T3 (es) Preparacion transdermica que contiene un metabolito de loratidina con accion antihistaminica.
FI950165A (fi) Ihon läpäisevä terapeuttinen järjestelmä, jossa vaikuttavana aineena on 17-beta-estradioli (vedetön)
DE68917651T2 (de) Aktiv-Matrix-Anzeigevorrichtung.
SE8502185L (sv) Anordning for att forhindra eller mildra snarkning
ATE289818T1 (de) Transdermales therapeutisches system mit einer östriol enthaltenden bisphosphatekombination

Legal Events

Date Code Title Description
FG2A Definitive protection

Ref document number: 610357

Country of ref document: ES